Sabra Healthcare REIT Inc [NASDAQ: SBRA] closed the trading session at $16.16.
The stocks have a year to date performance of 13.24 percent and weekly performance of -0.68 percent. The stock has been moved at 16.43 percent over the last six months. The stock has performed -2.59 percent around the most recent 30 days and changed 12.85 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 2.08M shares, SBRA reached to a volume of 2100114 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Sabra Healthcare REIT Inc [SBRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SBRA shares is $16.95 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SBRA stock is a recommendation set at 2.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Deutsche Bank have made an estimate for Sabra Healthcare REIT Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 30, 2024. The new note on the price target was released on October 17, 2023, representing the official price target for Sabra Healthcare REIT Inc stock. Previously, the target price had yet another raise from $13 to $15, while Wells Fargo kept a Equal Weight rating on SBRA stock. On October 10, 2023, analysts increased their price target for SBRA shares from 14 to 16.
The Average True Range (ATR) for Sabra Healthcare REIT Inc is set at 0.36, with the Price to Sales ratio for SBRA stock in the period of the last 12 months amounting to 5.58. The Price to Book ratio for the last quarter was 1.37, with the Price to Cash per share for the same quarter was set at 0.18. Price to Free Cash Flow for SBRA in the course of the last twelve months was 12.84.
SBRA stock trade performance evaluation
Sabra Healthcare REIT Inc [SBRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.68. With this latest performance, SBRA shares dropped by -2.59% in over the last four-week period, additionally plugging by 16.43% over the last 6 months – not to mention a rise of 35.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SBRA stock in for the last two-week period is set at 49.90, with the RSI for the last a single of trading hit 46.63, and the three-weeks RSI is set at 52.42 for Sabra Healthcare REIT Inc [SBRA]. The present Moving Average for the last 50 days of trading for this stock 15.78, while it was recorded at 16.16 for the last single week of trading, and 14.51 for the last 200 days.
Earnings per share (EPS) analysis for Sabra Healthcare REIT Inc [SBRA] stock
With the latest financial reports released by the company, Sabra Healthcare REIT Inc posted -0.07/share EPS, while the average EPS was predicted by analysts to be reported at 0.13/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.2. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SBRA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Sabra Healthcare REIT Inc go to 7.30%.
Sabra Healthcare REIT Inc [SBRA]: Institutional Ownership
There are presently around $94.46%, or 95.58%% of SBRA stock, in the hands of institutional investors. The top three institutional holders of SBRA stocks are: VANGUARD GROUP INC with ownership of 34.44 million shares, which is approximately 14.8801%. BLACKROCK INC., holding 34.39 million shares of the stock with an approximate value of $$529.56 million in SBRA stocks shares; and BLACKROCK INC., currently with $$329.66 million in SBRA stock with ownership which is approximately 9.2487%.
